We aim for sustainable performance over time to benefit patients, employees, shareholders and society. Solid financial results and maintaining the trust of society underpin our ability to create value.
Fourth quarter and full year 2024 results
January 31, 2025 | Basel, Switzerland
Media release: English (PDF 0.4 MB) | Deutsch (PDF 0.4 MB)
Condensed financial report (PDF 0.5 MB)
Watch the webcast
Download the podcast (MP3 30 MB)
Download the presentation (PDF 4.7 MB)
Read the transcript
Novartis Q4 2024 impact and sustainability update (PDF 1.0 MB)
Investors event calendar
View recent presentations and learn more about upcoming events.
March 12, 2025
Barclays Healthcare Conference
Miami, FL
Reporting and transparency hub
Read our regulatory filings; policies, codes and guidelines that govern our activities; and environmental, social and governance (ESG) disclosures.
Environmental, Social and Governance (ESG)
Novartis aims to hold itself to the highest standards of sustainability and ethical business practices. We take bold steps to increase access to medicines, tackle complex global health challenges, and do our part as a responsible corporate citizen.
ESG updates: February 2025 (PDF 1.0 MB) | October 2024 (PDF 0.6 MB) | July 2024 (PDF 0.9 MB) | April 2024 (PDF 1.0 MB)
Latest updates: Impact & Sustainability (PDF 1.9 MB) | Impact & Health Equity (PDF 9.9 MB) | Novartis Enterprise Risk Management (PDF 0.2 MB)
We have created a set of environmental, social and governance indices to signpost where our key disclosures can be found across our publications and channels. Novartis aims to report comprehensively and transparently for all stakeholders concerned with ESG topics.
Stocks